Analystreport

CymaBay Therapeutics Inc (NASDAQ: CBAY) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

CymaBay Therapeutics Inc.  (CBAY) 
Last cymabay therapeutics inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cymabay.com